CD4+ T lymphocytes, especially Th2 cells, contribute to the progress of renal fibrosis

American Journal of Nephrology

Volumn 36, Issue 4, 2012, Pages 386-396

  Liu, Lili ^a   Kou, Pei ^a   Zeng, Qiao ^a   Pei, Guangchang ^a   Li, Yueqiang ^a   Liang, Huifang ^c   Xu, Gang ^a   Chen, Sheng ^b  

^a Tongji Hospital   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

CD4+ T lymphocytes; Renal fibrosis; Th1; Th2

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; FIBRONECTIN; TRANSFORMING GROWTH FACTOR BETA; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE COURSE; FIBROGENESIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY FIBROSIS; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TH2 CELL;

ANIMALS; BIOPSY; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; FIBROSIS; FLOW CYTOMETRY; GLOMERULONEPHRITIS, IGA; HUMANS; KIDNEY; LYMPHOCYTE DEPLETION; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEPHROSIS, LIPOID; RENAL INSUFFICIENCY, CHRONIC; SEVERITY OF ILLNESS INDEX; TH1 CELLS; TH2 CELLS; URETERAL OBSTRUCTION;

EID: 84867212171     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000343283     Document Type: Article

References (32)

1. Zeisberg M, Neilson EG: Mechanisms of tubulointerstitial fibrosis. J Am Soc Nephrol 2010; 21: 1819-1834.
2. Nangaku M: Mechanisms of tubulointerstitial injury in the kidney: final common pathways to end-stage renal failure. Intern Med 2004; 43: 9-17.
3. Grande MT, Pérez-Barriocanal F, López-Novoa JM: Role of inflammation in túbulo-interstitial damage associated to obstructive nephropathy. J Inflamm (Lond) 2010; 7: 19.
4. Nathan C, Ding A: Nonresolving inflammation. Cell 2010; 140: 871-882.
5. Duffield JS: Macrophages and immunologic inflammation of the kidney. Semin Nephrol 2010; 30: 234-254.
6. Ricardo SD, van Goor H, Eddy AA: Macrophage diversity in renal injury and repair. J Clin Invest 2008; 118: 3522-3530.
7. Liu Y: Cellular and molecular mechanisms of renal fibrosis. Nat Rev Nephrol 2011; 7: 684-696.
8. Robertson H, Ali S, McDonnell BJ, Burt AD, Kirby JA: Chronic renal allograft dysfunction: the role of T cell-mediated tubular epithelial to mesenchymal cell transition. J Am Soc Nephrol 2004; 15: 390-397.
9. Anders HJ, Vielhauer V, Frink M, Linde Y, Cohen CD, Blattner SM, Kretzler M, Strutz F, Mack M, Gröne HJ, Onuffer J, Horuk R, Nelson PJ, Schlöndorff D: A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation. J Clin Invest 2002; 109: 251-259.
10. Vielhauer V, Anders HJ, Mack M, Cihak J, Strutz F, Stangassinger M, Luckow B, Grone HJ, Schlondorff D: Obstructive nephropathy in the mouse: progressive fibrosis correlates with tubulointerstitial chemokine expression and accumulation of CC chemokine receptor 2- and 5-positive leukocytes. J Am Soc Nephrol 2001; 12: 1173-1187.
11. Eis V, Luckow B, Vielhauer V, Siveke JT, Linde Y, Segerer S, Perez De Lema G, Cohen CD, Kretzler M, Mack M, Horuk R, Murphy PM, Gao JL, Hudkins KL, Alpers CE, Gröne HJ, Schlöndorff D, Anders HJ: Chemokine receptor CCR1 but not CCR5 mediates leukocyte recruitment and subsequent renal fibrosis after unilateral ureteral obstruction. J Am Soc Nephrol 2004; 15: 337-347.
12. Shappell SB, Gurpinar T, Lechago J, Suki WN, Truong LD: Chronic obstructive uropathy in severe combined immunodeficient (SCID) mice: lymphocyte infiltration is not required for progressive tubulointerstitial injury. J Am Soc Nephrol 1998; 9: 1008-1017.
13. Tapmeier TT, Fearn A, Brown K, Chowdhury P, Sacks SH, Sheerin NS, Wong W: Pivotal role of CD4+ T cells in renal fibrosis following ureteric obstruction. Kidney Int 2010; 78: 351-362.
14. Zhu J, Yamane H, Paul WE: Differentiation of effector CD4 T cell populations. Annu Rev Immunol 2010; 28: 445-489.
15. Tipping PG, Holdsworth SR: T cells in crescentic glomerulonephritis. J Am Soc Nephrol 2006; 17: 1253-1263.
16. De Paiva VN, Monteiro RM, Marques Vde P, Cenedeze MA, Teixeira Vde P, Dos Reis MA: Critical involvement of Th1-related cytokines in renal injuries induced by ischemia and reperfusion. Int Immunopharmacol 2009; 9: 668-672.
17. Henri S, Chevillard C, Mergani A, Paris P, Gaudart J, Camilla C, Dessein H, Montero F, Elwali NE, Saeed OK, Magzoub M, Dessein AJ: Cytokine regulation of periportal fibrosis in humans infected with Schistosoma mansoni: IFN-gamma is associated with protection against fibrosis and TNF-alpha with aggravation of disease. J Immunol 2002; 169: 929-936.
18. Oriente A, Fedarko NS, Pacocha SE, Huang SK, Lichtenstein LM, Essayan DM: Interleukin-13 modulates collagen homeostasis in human skin and keloid fibroblasts. J Pharmacol Exp Ther 2000; 292: 988-994.
19. Saito A, Okazaki H, Sugawara I, Yamamoto K, Takizawa H: Potential action of IL-4 and IL-13 as fibrogenic factors on lung fibroblasts in vitro. Int Arch Allergy Immunol 2003; 132: 168-176.
20. Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI, West AB: Myofibroblasts. I. Paracrine cells important in health and disease. Am J Physiol 1999; 277:C1-C9.
21. Tredget EE, Yang L, Delehanty M, Shankowsky H, Scott PG: Polarized Th2 cytokine production in patients with hypertrophic scar following thermal injury. J Interferon Cytokine Res 2006; 26: 179-189.
22. Shao DD, Suresh R, Vakil V, Gomer RH, Pilling D: Pivotal advance: Th-1 cytokines inhibit, and Th-2 cytokines promote fibrocyte differentiation. J Leukoc Biol 2008; 83: 1323-1333.
23. Niedermeier M, Reich B, Rodriguez Gomez M, Denzel A, Schmidbauer K, Gobel N, Talke Y, Schweda F, Mack M: CD4+ T cells control the differentiation of Gr1+ monocytes into fibrocytes. Proc Natl Acad Sci USA 2009; 106: 17892-17897.
24. Xing ZZ, Zhang DL, Li H, Chen H, Jia JD, Wang ZG: Rat renal interstitial fibroblasts affect the TH1/TH2 profile in vitro. Ren Fail 2011; 33: 1025-1031.
25. DC Cattran, R Coppo, HT Cook, et al: The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int 2009; 76: 534-545.
26. Chung AC, Lan HY: Chemokines in renal injury. J Am Soc Nephrol 2011; 22: 802-809.
27. Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE: RAG- 1-deficient mice have no mature B and T lymphocytes. Cell 1992; 68: 869-877.
28. Classen A, Lloberas J, Celada A: Macrophage activation: classical versus alternative. Methods Mol Biol 2009; 531: 29-43.
29. Mills CD, Kincaid K, Alt JM, Heilman MJ and Hill AM: M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol 2000; 164: 6166-6173.
30. Xing GQ, Chen M, Liu G, Zheng XEJ, Zhao MH: Differential deposition of C4d and MBL in glomeruli of patients with ANCAnegative pauci-immune crescentic glomerulonephritis. J Clin Immunol 2010; 30: 144-156.
31. Truscott SM, Abate G, Price JD, Kemper C, Atkinson JP, Hoft DF: CD46 engagement on human CD4+ T cells produces T regulatory type 1-like regulation of antimycobacterial T cell responses. Infect Immun 2010; 78: 5295-5306.
32. Sivasankar B, Longhi MP, Gallagher KM, Betts GJ, Morgan BP, Godkin AJ, Gallimore AM: CD59 blockade enhances antigen-specific CD4+ T cell responses in humans: a new target for cancer immunotherapy? J Immunol 2009; 182: 5203-5207.